Children born to mothers who used buprenorphine for opioid addiction during pregnancy do not have a greater risk of ...

Leads to superior rates of illicit opioid abstinence and improved outcomes compared with sublingual buprenorphine. HealthDay News — Injectable, extended-release buprenorphine is safe and effective in ...

Researchers found that buprenorphine for opioid use disorder treatment during pregnancy was linked to better outcomes for newborns than methadone and to similar outcomes for 8-year-olds.

Opioid use disorder during pregnancy remains a critical yet under-addressed public health issue in the U.S., according to a ...

Reassuring evidence on neurodevelopmental outcomes Opioid use disorder during pregnancy poses substantial risks of harm to ...

CLEVELAND, Ohio — A longer-acting medication may be more effective at helping pregnant women with opioid use disorder avoid illegal drugs, suggests new research from the University of Cincinnati.

A recent study published in the Journal of the American Medical Association revealed that extended-release buprenorphine ...

Taking medications for the treatment of opioid use disorder (MOUD) during pregnancy can improve maternal and fetal outcomes, lowering risk of maternal ...

In a randomized trial, both 100-mg and 300-mg monthly maintenance doses of extended-release buprenorphine improved opioid abstinence in patients with high-risk opioid use, with no new safety signals.